Quantum BioPharma Ltd.
QNTM
Price:
$10
Market Cap:
$38.17M
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
Stock Exchange
NASDAQ
Ticker
QNTM
PE Ratio
[-1.05]
ROE
[-289.99%]
Current Ratio
[0.78]
Dividend Yield
[0%]
Enterprise Value
[38.94M]
Dividend History
The Enterprise Value as of December 2025 (TTM) for Quantum BioPharma Ltd. (QNTM) is 38.94M
According to Quantum BioPharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 38.94M. This represents a change of 129.03% compared to the average of 17.00M of the last 4 quarters.
Quantum BioPharma Ltd. (QNTM) Historical Enterprise Value (quarterly & annually)
How has QNTM Enterprise Value performed in the past?
The mean historical Enterprise Value of Quantum BioPharma Ltd. over the last ten years is 86.31M. The current 38.94M Enterprise Value has changed 4.41% with respect to the historical average. Over the past ten years (40 quarters), QNTM's Enterprise Value was at its highest in in the September 2018 quarter at 885.54M. The Enterprise Value was at its lowest in in the December 2024 quarter at -1390173.20.
Average
86.31M
Median
39.66M
Minimum
-987077.04
Maximum
331.10M
Quantum BioPharma Ltd. (QNTM) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Quantum BioPharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.40%
Maximum Annual Enterprise Value = 331.10M
Minimum Annual Increase = -102.90%
Minimum Annual Enterprise Value = -987077.04
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | -987077.04 | -102.90% |
| 2023 | 34.00M | 141.55% |
| 2022 | 14.07M | 1.40% |
| 2021 | 940.33K | -47.00% |
| 2020 | 1.77M | -96.09% |
| 2019 | 45.32M | -86.31% |
| 2018 | 331.10M | 138.20% |
| 2017 | 139.00M | -6.52% |
| 2016 | 148.70M | -0.28% |
Quantum BioPharma Ltd. (QNTM) Average Enterprise Value
How has QNTM Enterprise Value performed in the past?
The current Enterprise Value of Quantum BioPharma Ltd. (QNTM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
15.70M
5-year avg
9.96M
10-year avg
86.31M
Quantum BioPharma Ltd. (QNTM) Enterprise Value vs. Peers
How is QNTM’s Enterprise Value compared to its peers?
Quantum BioPharma Ltd.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (30.06M), greater than Annovis Bio, Inc. (-17038803690.00), greater than Cumberland Pharmaceuticals Inc. (30.19M), greater than PolyPid Ltd. (31.37M), greater than Rockwell Medical, Inc. (32.30M), greater than Rein Therapeutics Inc. (32.49M), less than Celularity Inc. (112.66M), less than BioAtla, Inc. (47.72M), greater than Actinium Pharmaceuticals, Inc. (-7013958.00), greater than Evaxion Biotech A/S (29.95M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 30.06M | $40.31M | |
| -17038803690.00 | $91.48M | |
| 30.19M | $35.15M | |
| 31.37M | $40.15M | |
| 32.30M | $35.02M | |
| 32.49M | $36.54M | |
| 112.66M | $47.46M | |
| 47.72M | $49.86M | |
| -7013958.00 | $45.23M | |
| 29.95M | $33.41M |
Build a custom stock screener for Quantum BioPharma Ltd. (QNTM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum BioPharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Quantum BioPharma Ltd. (QNTM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Quantum BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Quantum BioPharma Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Quantum BioPharma Ltd. (QNTM)?
What is the 3-year average Enterprise Value for Quantum BioPharma Ltd. (QNTM)?
What is the 5-year average Enterprise Value for Quantum BioPharma Ltd. (QNTM)?
How does the current Enterprise Value for Quantum BioPharma Ltd. (QNTM) compare to its historical average?